HPTN 055

HIV Prevention Preparedness Study

Study Summary
Study Documents - Study Details* - Key Study Personnel* - Study SitesPublications
*Authenticated users only (create your account here)

What was HPTN 055?

A prospective cohort study to prepare for implementation of HPTN 035, A Phase II/III Safety and Effectiveness Study of the Vaginal Microbicides BufferGel and PRO 2000/5 Gel (P) for the Prevention of HIV Infection in Women

Who participated in the study?

Sexually active HIV-uninfected women from the study sites (240 participants per site)

What happened during the study?

No treatment regimen; however HIV/STD pre-test, risk reduction, and post-test counseling was provided each quarter, and STD treatment was provided as clinically indicated

Study Documents